Mesoblast Ltd
Ryoncil
Severe and life-threatening inflammatory conditions
Date
TBD
FDA decision · Date TBD estimated
What's at stake
The FDA's approval decision on Ryoncil for Severe and life-threatening inflammatory conditions is due Date TBD. A green light opens the market; a complete response letter (CRL) usually sinks the stock.
Primary source
· SEC 6-K
verified 13h ago
“Potential FDA approval and US launch Q2 CY2028”